Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.38 | - |
NAV | ₹9.72 | - |
Fund Started | 10 Nov 2025 | - |
Fund Size | ₹291.59 Cr | - |
Exit Load | Exit load of 0.50%, if redeemed within 30 days. | - |
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.38
-
NAV
₹9.72
-
Fund Started
10 Nov 2025
-
Fund Size
₹291.59 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
-
1 Year | - | - |
3 Year | - | - |
5 Year | - | - |
1 Year
-
-
3 Year
-
-
5 Year
-
-
Equity | 73.81% | - |
Cash | 25.95% | - |
Equity
73.81%
-
Cash
25.95%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.05% |
Apollo Hospitals Enterprise Ltd. | 7.55% |
Dr. Reddy's Laboratories Ltd. | 6.48% |
Cipla Ltd. | 6.30% |
Max Healthcare Institute Ltd. | 6.18% |
Divi's Laboratories Ltd. | 5.55% |
JB Chemicals & Pharmaceuticals Ltd. | 4.25% |
Ajanta Pharma Ltd. | 2.85% |
Syngene International Ltd. | 2.78% |
Glenmark Pharmaceuticals Ltd. | 2.00% |
-
Name | Viraj Kulkarni | - |
Start Date | 10 Nov 2025 | - |
Name
Viraj Kulkarni
-
Start Date
10 Nov 2025
-
Description | The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. | - |
Launch Date | 10 Nov 2025 | - |
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
-
Launch Date
10 Nov 2025
-